Reporting standards for endovascular chemotherapy of head, neck and CNS tumors. (Q38119427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Reporting standards for endovascular chemotherapy of head, neck and CNS tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Charles J. Prestigiacomo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mahesh Jayaraman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Michael E Kelly

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

11

Athos Patsalides

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

M Shazam Hussain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Cliff Eskey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Todd Abruzzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ketan Bulsara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Joey English

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kristine Blackham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Huy M Do

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jeffrey L Sunshine

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Philip Meyers

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Society for NeuroInterventional Surgery

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

4 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

Journal of NeuroInterventional Surgery

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

396-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Intracarotid cisplatin chemotherapy for recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Phase I Study of Intracarotid Administration of Carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Hyperselective intra-arterial preoperative chemotherapy in patients with squamous cell carcinoma of the oral cavity: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea]

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

Feasibility and Efficacy of Percutaneous Transcatheter Intraarterial Chemotherapy with Paclitaxel in Albumin Nanoparticles for Advanced Squamous-Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FNEURINTSURG-2013-010841

10.1136/NEURINTSURG-2013-010841

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828325%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference